Biocorrx (BICX) to Release Quarterly Earnings on Monday

Biocorrx (OTCMKTS:BICX) is expected to be issuing its results after the market closes on Monday, May 11th. Analysts expect the company to announce earnings of ($0.06) per share and revenue of $0.22 million for the quarter.

Biocorrx (OTCMKTS:BICX) last posted its earnings results on Tuesday, March 31st. The company reported $0.05 earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.11. The firm had revenue of ($0.15) million during the quarter, compared to analyst estimates of $0.22 million.

Biocorrx Trading Down 39.2%

Shares of BICX stock traded down $0.16 during trading hours on Monday, hitting $0.24. 1,900 shares of the company were exchanged, compared to its average volume of 7,789. The company has a market capitalization of $7.05 million, a PE ratio of -1.28 and a beta of 0.17. Biocorrx has a 52 week low of $0.20 and a 52 week high of $0.50. The business has a 50 day moving average of $0.37 and a two-hundred day moving average of $0.36.

About Biocorrx

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.